Business Context and Reporting Period
Company: Inter Parfums, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2006
Business Overview: Inter Parfums manufactures, markets, and distributes fragrances and related products globally. Operations are managed in two segments: European-based operations (prestige fragrances) and United States-based operations (specialty retail and mass-market products). The company operates primarily under license agreements with major brand owners.
Key Financial Metrics
| Metric | 2006 | 2005 | 2004 |
|---|---|---|---|
| Net Sales | $321.1 million | $273.5 million | $236.0 million |
| Gross Margin | 55% | 58% | 52% |
| Operating Income | $36.1 million | $31.4 million | $32.5 million |
| Net Income | $17.7 million | $15.3 million | $15.7 million |
| Diluted EPS | $0.86 | $0.75 | $0.77 |
| Cash & Short-Term Investments | $71.0 million | $59.5 million | $41.0 million |
| Working Capital | $138.5 million | $131.1 million | $129.9 million |
| Total Debt (Short & Long Term) | $16.8 million | $14.2 million | $20.4 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17% to $321.1 million, driven by a 13% increase in European prestige sales and a 49% surge in U.S. specialty retail sales.
- Profitability: Net income rose 16% to $17.7 million. However, gross margins declined from 58% to 55% due to a higher mix of lower-margin U.S. sales relative to high-margin European sales.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 12% to $141.1 million, primarily due to increased royalties and advertising requirements under the Burberry license and start-up costs for the Gap partnership.
- Cash Flow: Operating cash flow decreased significantly to $13.4 million (from $30.4 million in 2005) due to a 33% increase in inventory levels to support new product launches.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Strategic Targets: Management targets organic long-term sales growth of approximately 10% and net income growth of 12-15% annually.
- Upcoming Launches: Anticipated launches include a Gap fragrance family (May 2007), a Roxy fragrance family (late 2007), and a new Van Cleef & Arpels line (2008).
- Dividends: The board increased the annual cash dividend to $0.20 per share (from $0.16), payable quarterly.
Risks and Contingencies
- License Concentration: Burberry products represented 57% of net sales in 2006. Loss of this license would have a material adverse effect.
- Van Cleef & Arpels Commitment: The company agreed to pay a lump-sum upfront royalty of approximately $23.4 million (€18 million) in January 2007 for the new license, creating a significant near-term cash outflow.
- Gap Dependency: U.S. growth is heavily reliant on the marketing and sales efforts of The Gap, Inc., over which Inter Parfums has limited control.
- Currency Risk: Approximately 34% of prestige sales are denominated in U.S. dollars, exposing the company to Euro/USD exchange rate fluctuations.
Investor Verification Checklist
- Burberry Performance: Verify continued sales momentum of the Burberry brand, which accounts for over half of total revenue.
- Van Cleef & Arpels Integration: Monitor the successful launch and market acceptance of the new Van Cleef & Arpels fragrance line in 2008 to justify the $23.4 million upfront payment.
- Gap Partnership Execution: Assess the performance of the Gap and Banana Republic fragrance launches scheduled for 2007 to ensure the 49% U.S. sales growth is sustainable.
- Inventory Management: Review inventory turnover rates to ensure the significant inventory buildup in 2006 does not lead to future write-downs or cash flow constraints.
- License Renewals: Track the status of key license renewals, specifically Burberry (option to extend in 2014) and Celine (terminating Dec 31, 2007).